1 / 13

Vaccination and auto-immunity : reassessing evidence

Vaccination and auto-immunity : reassessing evidence Marc GIRARD, MSc, MD 1 bd de la République 78000-Versailles (France) Vaccination, Infection & Automminunity: Myth & Reality (Lausanne, 26-28 October 2005). Auto-immune hazards. Individual toxicity (1 vaccine)

margo
Download Presentation

Vaccination and auto-immunity : reassessing evidence

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Vaccination and auto-immunity : reassessing evidence Marc GIRARD, MSc, MD1 bd de la République 78000-Versailles (France) Vaccination, Infection & Automminunity:Myth & Reality (Lausanne, 26-28 October 2005)

  2. Auto-immune hazards • Individual toxicity (1 vaccine) • Additive effect ( 2 vaccines) • Interactive effect ( 2 vaccines) + +

  3. “ADVERSE REACTIONS ENGERIX-B is generally well tolerated (…) In 36 clinical studies, a total of 13,495 doses of ENGERIX-B were administered to 5,071 healthy adults and children (…) All subjects were monitoredfor 4 dayspost-administration (…)”. Physician Desk Reference

  4. “(…) Researchers analysed the US Vaccine Adverse Event Reporting System (VAERS) database for serious neurological symptoms (…) MHRA dismisses study findings (…) The MHRA notes that the authors failed to consider the limitations and biasesinherent in VAERS data (…)”. MHRA: Study on safety of MMR vaccine by Geier and Geier - conclusions are not justified. Internet-Document, 22 May 2003.

  5. “ (…) The Vaccine Adverse Event Reporting System (VAERS) in the US is a useful surveillance system for ensuring the safety of vaccines, according to researchers from the US FDA and Centres for Disease Control and Prevention (CDC) (…)” Morbidity-and-Mortality-Weekly-Report, vol. 52, page 1-26, 24 January 2003

  6. “(…) Since tolcapone was marketed, there had been 10 reports of serious hepatic adverse reactions (…) The CPMP considered that the overall balance of risks and benefitsof tolcapone was no longer favourable (…) Consequently, tolcapone was voluntarily withdrawn (…)” Current Problem in Pharmacovigilance (25 Feb 1999)

  7. Vaccine Number of case reports prior to 1995 1983-2004 HBV 42 102 Measle or MMR 20 40 Tetanus or DTP 13 27 Haemophilus influenzaetype b 4 7 Polio or DTP 3 3 Published case reports on various vaccine hazards in REACTIONS database

  8. Data of health insurance system (France)

  9. Data of health insurance system (France)

  10. “Dear Dr Girard On the basis of the advice I have received I have decided not to go ahead with your publication. X… Emeritus Professor of Science and Engineering Ethics”

  11. Conclusions • Vaccine R&D: the zero-level of EBM • HBV: unusually toxic (esp. for a vaccine) • A moral responsibility for each of us

More Related